In 246 children from the LAMP trial randomised to taper vs stop 0.05% atropine, myopia progressed less over 3 years with tapering (−0.54 vs −0.78 D; difference −0.24 D), and good response after discontinuation was more common (65.1% vs 42.6%); 180 completed follow-up.
RCTn = 246
Zhang et al. Discontinuation Approach and Follow-Up of Low-Concentration Atropine for Myopia Progression: Eight-Year Results of the LAMP Randomized Clinical Trial